Henry Schein, Inc. (HSIC)
| Market Cap | 11.11B |
| Revenue (ttm) | 10.62B |
| Net Income (ttm) | 439.53M |
| Shares Out | 142.30M |
| EPS (ttm) | 3.07 |
| PE Ratio | 26.14 |
| Forward PE | 20.70 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 29 |
| Last Price | $80.22 |
| Previous Close | $79.44 |
| Change ($) | 0.78 |
| Change (%) | 0.98% |
| Day's Open | 79.78 |
| Day's Range | 79.40 - 80.32 |
| Day's Volume | 435,745 |
| 52-Week Range | 56.31 - 83.45 |
Henry Schein's (HSIC) PPE sales from medical business are likely to have maintained momentum in Q2. Also, global recovery trends of its dental business are expected to reflect on Q2 results.
HSIC vs. COO: Which Stock Is the Better Value Option?
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will r...
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...
Dental stocks like Henry Schein (HSIC), Align Technology (ALGN), Straumann Holding (SAUHF) and DENTSPLY SIRONA (XRAY) are expected to continue their run over the next few months.
Stocks like Henry Schein (HSIC), BellRing Brands (BRBR), Harrow Health (HROW) and West Pharmaceuticals Services (WST) are solid low-beta picks with strong fundamentals.
HSIC vs. COO: Which Stock Is the Better Value Option?
Top Ranked Growth Stocks to Buy for July 1st
Grab these three top stocks, EYE, WST and HSIC, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.
Top Ranked Growth Stocks to Buy for June 29th
Top Ranked Growth Stocks to Buy for June 24th
Top Ranked Growth Stocks to Buy for June 23rd
Investors continue to be optimistic about Henry Schein (HSIC) on its extensive global foothold and bullish 2021 earnings guidance.
Fundamentally-sound stocks like Henry Schein (HSIC), UnitedHealth Group (UNH) and Phibro Animal Health (PAHC) are trading at a discount and make great picks for the long term.
MELVILLE, N.Y.--(BUSINESS WIRE)-- #HENRYSCHEIN--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in the Southeast that the Henry Schein Customer Assistance Hotline is open for dentists and physic...
New Strong Buy Stocks for June 18th
HSIC vs. COO: Which Stock Is the Better Value Option?
Top Ranked Growth Stocks to Buy for June 18th
Here we look at three stocks, VEEV, HSIC and BDX, that investors can keep a watch on the back of their robust cybersecurity measures.
Top Ranked Growth Stocks to Buy for June 15th
Henry Schein's (HSIC) acquisition of majority stake in eAssist will enable it to offer best quality solutions to help dental practices operate efficiently and profitably.
These five MedTech stocks, EYE, MRVI, SONVY, SARTF and HSIC, all with a favorable Zacks Rank and growth parameters are expected to put up a robust performance in 2021.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. acquires majority interest in eAssist Dental Solutions.
Top Ranked Growth Stocks to Buy for June 8th
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
HSIC vs. SAUHF: Which Stock Is the Better Value Option?
Henry Schein (HSIC) to extend effective inventory management and extensive logistical support for PPE and COVID related products within the spectrum of U.S. health care.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. awarded Strategic National Stockpile contract for PPE storage and distribution.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein One acquires majority interest in Jarvis Analytics.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Donates More than 2.5 Million Personal Protective Equipment and Infection Control Items to Health Care Workers in Brazil and India
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to present at four virtual investor conferences in June 2021.
Investors are optimistic about Henry Schein (HSIC) on solid first-quarter performance and strategic deals.
HSIC vs. CNMD: Which Stock Is the Better Value Option?
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. elects Reed V. Tuckson, M.D., FACP to the Company's Board of Directors.
The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors. Among the featured segments was one from Chris Capre on h...
Henry Schein's (HSIC) latest software module is expected to provide better patient care and improved patient experience.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein announces $400 million increase to share repurchase plan.
As of late, it has definitely been a great time to be an investor in Henry Schein, Inc. (HSIC).
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today a series of ef...
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One Announces Enhancement of its AxiUm Dental Software by Integrating Dental and Medical Patient Records
Henry Schein (HSIC) is optimistic about maintaining robust sales of PPE and COVID-19-related products.
Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Henry Schein (HSIC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ...
Henry Schein Inc (NASDAQ: HSIC) raised its 2021 guidance after reporting first-quarter earnings, which topped the consensus. It posted an adjusted EPS of $1.24 ahead of the consensus of $0.85.
Henry Schein (HSIC) sees robust segmental performance in Q1 boosted by strong rebound in sales, and solid demand for PPE and COVID-19-related products.
Henry Schein (HSIC) delivered earnings and revenue surprises of 49.40% and 3.55%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Henry Schein (NASDAQ:HSIC) decreased 3.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 31.91% over the past year to $1.24, which ...
About HSIC
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives... [Read more...]
| Industry Medical Distribution | IPO Date Nov 3, 1995 |
| CEO Stanley Bergman | Employees 20,000 |
| Stock Exchange NASDAQ | Ticker Symbol HSIC |
Financial Performance
In 2020, Henry Schein's revenue was $10.12 billion, an increase of 1.34% compared to the previous year's $9.99 billion. Earnings were $403.79 million, a decrease of -41.88%.
Analyst Forecasts
According to 17 analysts, the average rating for Henry Schein stock is "Buy." The 12-month stock price forecast is 83.31, which is an increase of 3.85% from the latest price.